Nantahala Capital Management, LLC Syndax Pharmaceuticals Inc Transaction History

Nantahala Capital Management, LLC

$1.99 Billion
Q4 2024

A detailed history of Nantahala Capital Management, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 560,532 shares of SNDX stock, worth $8.36 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

560,532

Previous 453,232 23.67%

Holding current value

$8.36 Million

Previous $8.72 Million 15.06%

% of portfolio

0.37%

Previous 0.52%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $1.34 Million - $2.34 Million	107,300 Added 23.67%	560,532 $7.41 Million
Q2 2024 Aug 14, 2024	SELL	$18.82 - $23.79 $226,348 - $286,122	-12,027 Reduced 2.59%	453,232 $9.3 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $1.97 Million - $2.46 Million	100,000 Added 27.38%	465,259 $11.1 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $1.43 Million - $2.71 Million	125,228 Added 52.17%	365,259 $7.89 Million
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $1.21 Million - $1.81 Million	-83,103 Reduced 25.72%	240,031 $3.49 Million
Q2 2023 Aug 14, 2023	SELL	$19.35 - $22.31 $12.6 Million - $14.6 Million	-652,571 Reduced 66.88%	323,134 $6.76 Million
Q4 2022 Feb 14, 2023	SELL	$20.64 - $26.24 $8.25 Million - $10.5 Million	-399,723 Reduced 29.06%	975,705 $24.8 Million
Q3 2022 Nov 10, 2022	SELL	$18.51 - $24.79 $23.8 Million - $31.9 Million	-1,287,659 Reduced 48.35%	1,375,428 $33.1 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $398,506 - $569,127	-29,216 Reduced 1.09%	2,663,087 $51.2 Million
Q1 2022 May 13, 2022	SELL	$14.84 - $22.15 $2.35 Million - $3.51 Million	-158,256 Reduced 5.55%	2,692,303 $46.8 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $2.95 Million - $4.35 Million	193,400 Added 7.28%	2,850,559 $62.4 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $885,211 - $1.26 Million	63,822 Added 2.46%	2,657,159 $50.8 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $7.93 Million - $14.9 Million	590,927 Added 29.51%	2,593,337 $44.5 Million
Q1 2021 May 14, 2021	BUY	$19.28 - $24.59 $3.93 Million - $5.02 Million	203,957 Added 11.34%	2,002,410 $44.8 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $6.94 Million - $12.2 Million	459,762 Added 34.34%	1,798,453 $40 Million
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $17.9 Million - $23.4 Million	1,338,691 New	1,338,691 $19.8 Million

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

95.1M

Call Options Held

759K

Put Options Held

635K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $844M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account

Nantahala Capital Management, LLC Syndax Pharmaceuticals Inc Transaction History